PendiumPendium

Step 1 of 9

Cost Plus Drugs owns the transparency narrative, but competitors are starting to mirror the language.

While your visibility is excellent for generic discovery, there is room to capture more of the chronic care management conversation as competitors launch similar low-cost programs.

Mark Cuban Cost Plus Drug Company's baseline score
76/100
Good

Cost Plus Drugs has a dominant visibility profile in the generic medication space, driven by high-authority news citations and Mark Cuban's profile. AI agents treat the 15% markup as a canonical fact, making the brand the default recommendation for cost-conscious patients.

What we see
  • The brand has exceptional visibility in ChatGPT and Claude due to massive national media coverage and Wikipedia presence.
  • Gemini surfaces the brand frequently because of its high rankings for 'cost of [drug name]' search queries.
  • AI Overviews often include the brand in 'how to save money on meds' lists, pulling from Reddit threads and consumer advocacy sites.
  • Visibility drops for specific brand-name drug queries where traditional pharmacies still dominate the SEO and citation landscape.
  • Reddit mentions in communities like r/health and r/frugal serve as a persistent trust signal for all four major AI models.
Business goals Mark Cuban Cost Plus Drug Company is likely trying to hit
  • Increase patient signups for chronic condition maintenance medications
  • Secure more partnerships with self-insured employer health plans
  • Expand the list of available generic drugs to cover more specialized conditions
  • Educate consumers on the difference between cost-plus pricing and traditional PBM models